DSFIR DSM-Firmenich AG

115.69USD105.25 EUR · AMS+0.77%Mkt Cap: 28.06B USDP/E: —

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates t…

Institutional holders12 on file

Key Statistics

Company
Market Cap28.06B USD
Enterprise Value33.79B USD
Revenue (TTM)9.95B USD
Gross Profit3.88B USD
Net Income (TTM)-1.19B USD
Revenue/Share39.40 USD
Last Price115.69 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees20.8K
CountryNL
SectorBasic Materials
IndustrySpecialty Chemicals
ISINCH1216478797
Valuation
P/E (Trailing)—
P/E (Forward)24.85
PEG0.80
EV/EBITDA21.46
EV/Revenue3.39
P/S2.82
P/B1.47
EPS (TTM)-5.89 USD
EPS (Forward)4.62 USD
52W Range
60.7086% of range124.70
52W High124.70 USD
52W Low60.70 USD
Profitability
Gross Margin39.07%
Oper. Margin6.80%
EBITDA Margin15.81%
Profit Margin-11.97%
ROE-5.93%
ROA-3.68%
ROIC2.30%
ROCE2.66%
Growth
Revenue Growth0.50%
Earnings Growth-56.20%
Cash Flow & Leverage
Operating CF1.59B USD
CapEx (TTM)872.76M USD
FCF Margin-0.20%
FCF Yield-0.07%
Net Debt4.90B USD
Net Debt/EBITDA3.11
Net Debt/FCF—
Balance Sheet
Debt/Equity0.29
Current Ratio1.75
Quick Ratio0.82
Book Value/Sh78.31 USD
Cash/Share10.14 USD
Dividends
Fwd Div Rate2.75 USD
Trail. Div Rate2.75 USD
Div. Yield2.39%
5Y Avg Yield—
Payout Ratio206.61%
Ex-Div DateMay 11, 2026
Pay Date—
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)113.40 USD
Upside (mean)-2.0%
Target Range81.78 USD – 137.40 USD
81.78-2.0% to mean137.40
# Analysts20
Ownership
Shares Out.244.36M
Float225.42M
Insiders9.49%
Institutions53.74%
Technical
SMA 50111.91 (+3.4%)
SMA 20088.51 (+30.7%)
Beta0.50
S&P 52W Chg12.00%
Avg Vol (30d)583.00K
Avg Vol (10d)605.91K
Technical Indicators
RSI (14)48.3
MACD0.4008
MACD Signal1.2044
MACD Hist.-0.8036
BB Upper122.40 USD
BB Middle117.37 USD
BB Lower112.33 USD
BB Width8.58%
ATR (14)2.915 USD
Vol Ratio (20d)0.61x

About DSM-Firmenich (AMS: DSFIR)

›

DSM-Firmenich (AMS: DSFIR) is listed on Euronext Amsterdam, where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 20,786 employees.

The shares were at 105.25 EUR on 20 November 2026, up 55.9% over 52 weeks. Its 52-week range is 55.22 EUR to 113.45 EUR: the price is 7.2% below the high and 90.6% above the low.

Its market capitalisation is 25.52B EUR. It pays a dividend yielding 2.39% (it pays out 207% of its earnings), against a median of 1.83% among the dividend payers in that peer group.

DSM-Firmenich reports return on equity of -5.9%, an operating margin of 6.8% and revenue up 0.5% year over year.

Its debt exceeds its cash by 4.46B EUR, a debt-to-equity ratio of 0.29. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 103.17 EUR is 2.0% below the current price. The next earnings report is expected on 9 February 2027.